DarioHealth Corp. (DRIO)
NASDAQ: DRIO · IEX Real-Time Price · USD
-0.090 (-7.32%)
At close: Apr 15, 2024, 4:30 PM
-0.080 (-7.02%)
Pre-market: Apr 16, 2024, 7:00 AM EDT

DarioHealth Statistics

Total Valuation

DarioHealth has a market cap or net worth of $33.56 million. The enterprise value is $26.02 million.

Market Cap 33.56M
Enterprise Value 26.02M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date May 9, 2024
Ex-Dividend Date n/a

Share Statistics

DarioHealth has 29.44 million shares outstanding. The number of shares has increased by 20.04% in one year.

Shares Outstanding 29.44M
Shares Change (YoY) +20.04%
Shares Change (QoQ) +0.30%
Owned by Insiders (%) 14.81%
Owned by Institutions (%) 29.43%
Float 23.92M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.65
Forward PS 0.88
PB Ratio 0.58
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.28
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.79, with a Debt / Equity ratio of 0.51.

Current Ratio 3.79
Quick Ratio 3.38
Debt / Equity 0.51
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -91.80% and return on invested capital (ROIC) is -64.08%.

Return on Equity (ROE) -91.80%
Return on Assets (ROA) -59.30%
Return on Capital (ROIC) -64.08%
Revenue Per Employee $73,739
Profits Per Employee -$230,112
Employee Count 276
Asset Turnover 0.19
Inventory Turnover 2.21


In the past 12 months, DarioHealth has paid $64,000 in taxes.

Income Tax 64,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -67.80% in the last 52 weeks. The beta is 1.66, so DarioHealth's price volatility has been higher than the market average.

Beta (1Y) 1.66
52-Week Price Change -67.80%
50-Day Moving Average 1.72
200-Day Moving Average 2.31
Relative Strength Index (RSI) 34.18
Average Volume (30 Days) 138,656

Short Selling Information

The latest short interest is 1.36 million, so 4.63% of the outstanding shares have been sold short.

Short Interest 1.36M
Short Previous Month 1.34M
Short % of Shares Out 4.63%
Short % of Float 5.69%
Short Ratio (days to cover) 11.53

Income Statement

In the last 12 months, DarioHealth had revenue of $20.35 million and -$63.51 million in losses. Loss per share was -$1.93.

Revenue 20.35M
Gross Profit 5.98M
Operating Income -56.19M
Pretax Income -59.36M
Net Income -63.51M
EBITDA -54.38M
EBIT -59.36M
Loss Per Share -$1.93
Full Income Statement

Balance Sheet

The company has $37.09 million in cash and $29.54 million in debt, giving a net cash position of $7.55 million or $0.26 per share.

Cash & Cash Equivalents 37.09M
Total Debt 29.54M
Net Cash 7.55M
Net Cash Per Share $0.26
Equity / Book Value 58.14M
Book Value Per Share 1.97
Working Capital 34.84M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$30.38 million and capital expenditures -$584,000, giving a free cash flow of -$30.96 million.

Operating Cash Flow -30.38M
Capital Expenditures -584,000
Free Cash Flow -30.96M
FCF Per Share -$1.09
Full Cash Flow Statement


Gross margin is 29.40%, with operating and profit margins of -276.09% and -312.06%.

Gross Margin 29.40%
Operating Margin -276.09%
Pretax Margin -291.68%
Profit Margin -312.06%
EBITDA Margin -267.19%
EBIT Margin -291.68%
FCF Margin -152.14%

Dividends & Yields

DarioHealth does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -20.04%
Shareholder Yield -20.04%
Earnings Yield -189.22%
FCF Yield -92.25%

Analyst Forecast

The average price target for DarioHealth is $5.37, which is 371.05% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.37
Price Target Difference 371.05%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 55.86%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on November 18, 2019. It was a reverse split with a ratio of 1:20.

Last Split Date Nov 18, 2019
Split Type Reverse
Split Ratio 1:20


DarioHealth has an Altman Z-Score of -5.94 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.94
Piotroski F-Score 2